Molecular Templates Inc.

AI Score

0

Unlock

0.00
-0.00 (-100.00%)
At close: Feb 07, 2025, 2:19 PM
0.11
37000.00%
After-hours Dec 24, 2024, 04:58 PM EST
undefined%
Bid 0.11
Market Cap 1.98K
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -3.05
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.11
Volume 116
Avg. Volume (20D) 11,379,122
Open 0.00
Previous Close 0.00
Day's Range 0.00 - 0.00
52-Week Range 0.00 - 4.12
Beta undefined

About MTEM

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cance...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 4, 2005
Employees 62
Stock Exchange NASDAQ
Ticker Symbol MTEM

Next Earnings Release

Molecular Templates Inc. is scheduled to release its earnings on Feb 18, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-54.29%
Molecular Templates shares are trading lower after... Unlock content with Pro Subscription
3 months ago
+186.07%
Molecular Templates shares are trading higher amid volatility after the company recently announced it approved the liquidation and wind-up.